Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-969-4 | CAS number: 90-15-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2004 - August 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 1997
- Deviations:
- yes
- Remarks:
- The first trial and the third trial (in the presence of metabolioc activation) wereunacceptable due to excessive cytotoxicity. The second trial in the presence of metabolic activation was terminated due to a technical error.
- GLP compliance:
- yes
- Type of assay:
- other: mammalian cell gene mutation assay
Test material
- Reference substance name:
- 1-naphthol
- EC Number:
- 201-969-4
- EC Name:
- 1-naphthol
- Cas Number:
- 90-15-3
- Molecular formula:
- C10H8O
- IUPAC Name:
- naphthalen-1-ol
- Test material form:
- solid: flakes
- Details on test material:
- Light cream flakes
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: n°batch I-38110
- Expiration date of the lot/batch: 14 Jan 2006
- Purity test date: No data
- Purity : 99.9%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
- Stability under test conditions: Yes
- Solubility and stability of the test substance in the solvent/vehicle: Yes
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: No data
TREATMENT OF TEST MATERIAL PRIOR TO TESTING : No
FORM AS APPLIED IN THE TEST : solution
Method
- Target gene:
- Thymidine Kinase (TK) Locus
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Dr Donald Clive, Glaxo-Wellcome Inc. Research Triangel Park N.C.
- Methods for maintenance in cell culture if applicable: Yes (maintained in logarithmic growth by serial subculturing for up to 4 monthsand replaced by cells from the frozen stock - Cultures were grown in a shaker incubator at 35-38°C).
MEDIA USED
- Type and identity of media : RPMI 1640 (Amacher et al., 1980; Clive et al., 1987) supplemented with horse serum (10% by volume), Pluronic® F68, L-glutamine, sodium pyruvate, penicillin and streptomycin
- Properly maintained: Yes
- Periodically checked for Mycoplasma contamination: Yes
- Periodically checked for karyotype stability: Yes
- Periodically 'cleansed' against high spontaneous background: Yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- NADP/ Isoitrate induced Rat liver S9
- Test concentrations with justification for top dose:
- With metabolic activation: 0.4, 0.6, 0.8, 1, 1.2, 1.3, 1.4, 1.6 μg/ml
Without metabolic activation: 10, 20, 40, 50, 60, 70, 80, 90, 100 and 150 μg/ml
Justification of the top dose : A preliminary toxicity test was conducted. In the presence of metabolic activation ten concentrations were tested ranging from 0.0313 to 4 μg/ml and in the absence of metabolic activation 10 concentrations ranging from 2.35 to 1200 μg/ml. Severe toxicity was observed > 2 μg/ml in the presence of metabolic activation and > 75 μg/ml in the absence of metabolic activation - Vehicle / solvent:
- - Solvent used: DMSO (batch n° I-38110)
- Justification for choice of solvent/vehicle: solubility properties
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- methylmethanesulfonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:; The cells were pelleted by centrifugation, the culture medium removed, and the cells resuspended to a final volume of 10 mL of treatment medium with a final serum concentration of approximately 3%. The tubes were placed in an orbital shaker incubator at 35-38°C and rotated at 70 ± 10 orbits per minute
- Cell density at seeding: 6*10E6 cells per tube
DURATION
- Preincubation period: none
- Exposure duration: 4h
- Expression time (cells in growth medium): 48h
- Fixation time (start of exposure up to fixation or harvest of cells): 12 days
NUMBER OF REPLICATIONS: one per concentration
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: A total of 3 x 10E6 cells from each selected tube was suspended in selection medium in soft agar to recover TFT-resistant mutants. This sample was distributed into three 100 mm dishes. The absolute selection cloning efficiency was determined by seeding three dishes with a total of approximately 600 cells in agar cloning medium. All dishes were placed in an incubator at 35-38°C with 4-6% CO2:95% humidified air. After 12 days in the incubator, the colonies were counted with the Loats Associates, Inc. (LAI) High Resolution Colony Counter (HRCC) System for the Mouse Lymphoma Assay, version 2.3.1 build 1
NUMBER OF CELLS EVALUATED: 3 x 10E6
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
- OTHER:: size distribution of colonies - Rationale for test conditions:
- -
- Evaluation criteria:
- Mutant frequency and cell survival (measured as relative total growth) were determined. In addition to the numbers of mutant colonies, the size of the colonies were determined and the ratio of small versus large colonies was calculated.
For the mutant Selection Data
The mutant selection data includes the total mutant colonies and the total viable colonies. These were used to calculate the mutant frequency for each culture. The ratio of cells seeded for mutant selection to cells seeded for cloning efficiency was 0.5 x 104. Therefore, the mutant frequency was: (total mutant colonies/total viable colonies) x 2 x 10-4. Mutant frequency was given in units of 10-6. Also included in this section was the absolute cloning efficiency of vehicle and positive controls calculated as (total number of viable colonies/600) x 100%. - Statistics:
- Various models of calculators, computers, and computer programs were used to analyze data in this study. Because different models round off or truncate numbers differently, values in some tables (e.g., means, standard deviations, or individual values) may differ slightly from those in other tables, from individually calculated data, or from statistical analysis data. Neither the integrity nor the interpretation of the data was affected by these differences.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Remarks:
- at 90 µg/L, 4h exposure
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: not affected.
- Effects of osmolality: not increased
- Evaporation from medium : not specified
- Water solubility : no specified
- Precipation : not affected
Other cofounding effects : none
RANGE-FINDING/SCREENING STUDIES: Yes. In the absence of metabolic activity, 1-naphthol induced no cytotoxicity to weak cytotoxicity up to and including 37.5 μg/mL, moderately high cytotoxicity at 75.0 μg/mL and excessive cytotoxicty at ≥150 μg/mL. In the presence of metabolic activity, 1-naphthol induced excessive cytotoxicity at all doses tested
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%) : Performed
- Positive historical control data: nonactivation studies - 13 µg/mL methy methanesulfonate (mean 344.3 +/-72.3x10E-6, range 227 to 487.4x10E-6 ; number of experiments 50) - nonactivation studies - 2 µg/mL 3-methylcholanthrene (mean 339.1 +/-60.8x10E-6, range 211.0 to 491 x 10E-6 ; number of experiments 50) - nonactivation studies - 4 µg/mL 3-methylcholanthrene (mean 365.2 +/-69.5 x10E-6, range 200.2 0 to 524 x 10E-6 ; number of experiments 50)
- Negative (solvent/vehicle) historical control data: nonactivation studies (mean 63 +/-24.5x10E-6, range 36.4 to 135.7x10E-6 ; number of experiments 50) - activation studies (mean 63.3 +/-18 x10E-6, range 34 to 123.9 x10E-6 ; number of experiments 50)
TEST ARTICLE/ VEHICULE MIXTUE CONCENTRTION ANALYSES
Results of frozen stability analyses indicated that the formulations were stable for 9 days at -10 to -30°C. All values were within 3.1% of initial concentration. Results of concentration verification analyses indicated that all formulations were within 7.5% of target.
Any other information on results incl. tables
Initial Nonactivation Mutation Assay (B3)
In the initial nonactivation mutation assay, the average background mutant frequency (142.5x10-6) was outside the acceptable range specified in the protocol (20-130 x10-6); therefore, a repeat trial was performed using the same doses as the initial trial. The repeat nonactivation mutation assay with a treatment period of approximately 4 hours was initiated with twelve concentrations at 2.50, 5.00, 10.0, 20.0, 40.0, 50.0, 60.0, 70.0, 80.0, 90.0, 100 and 150 μg/mL. Treatments at and below 5.00 μg/mL were terminated because a sufficient number of higher concentrations were available and treatments above 90.0 μg/mL were terminated due to excessive cytotoxicity. The remaining eight treatments induced no cytotoxicity to high cytotoxicity (93.6% to 10.5% relative total growths). Mutant frequencies for the treatments analyzed ranged from 59.8 to 169.5 x 10-6. The background mutant frequency for the vehicle control in the initial nonactivation assay was 49.8 x 10-6, therefore a mutant frequency greater than or equal to 139.8 x 10-6 was required for a treatment to be evaluated as exhibiting a positive response. Treatments at 60.0, 70.0 and 90.0 μg/mL induced a mutant frequency that met criteria for a positive response.
Initial Activation Mutation Assay (B4)
Four mutation assays in the presence of metabolic activation were initiated, but the first trial was unacceptable due to excessive cytotoxicity. The second mutation assay in the presence of metabolic activation was terminated due to a technical error during dosing. The third mutation assay in the presence of metabolic activation was also terminated due to excessive cytotoxicity. The fourth mutation assay was considered acceptable and described in this report. The fourth activation assay with a treatment period of approximately 4 hours was initiated with twelve treatments at 0.200, 0.400, 0.600, 0.800, 1.00, 1.20, 1.30, 1.40, 1.60, 1.80, 2.00, and 2.40 μg/mL. The treatment at 0.200 μg/mL was terminated because a sufficient number of higher concentrations were available and treatments above 1.60 μg/mL were terminated due to excessive cytotoxicity. The remaining eight treatments induced no cytotoxicity to high cytotoxicity (106.3% to 15.9% relative total growth). Mutant frequencies for the treatments analyzed ranged from 95.8 to 50.0 x 10-6. The average background mutant frequency for the vehicle control in the initial activation assay was 53.3 x 10-6, therefore a mutant frequency greater than or equal to 143.3 x 10-6 was required for a treatment to be evaluated as exhibiting a positive response (Table 5). None of the treatments induced dose-responsive increases in mutant frequencies that met the criteria for a
positive response.
Confirmatory Mutation Assay
A confirmatory assay is not needed when clear positive results are observed in the initial definitive mutagenicity assay (OECD Guideline 476, 1997 and ICH S2A, 1996). In this study, clear positive results were obtained in the presence of S9.
Applicant's summary and conclusion
- Conclusions:
- Under the test conditions used 1-naphthol is considered mutagenic in the absence of metabolic activation.
- Executive summary:
The test substance was examined for its mutagenic activity in the L5178Y tk+/- mouse lymphoma test in the absence and presence of metabolic activation. A preliminary toxicity test was conducted. In the presence of metabolic activation ten concentrations were tested ranging from 0.0313 to 4 μg/ml and in the absence of metabolic activation 10 concentrations ranging from 2.35 to 1200 μg/ml. As positive controls MMS (methyl methanesulfonate) for testing without metabolic activation and MCA (methylcholanthrene) for testing with metabolic activation were used.
Results
In the preliminary toxicity test, severe toxicity was observed > 2 μg/ml in the presence of metabolic activation and > 75 μg/ml in the absence of metabolic activation. Based on these data the main experiment was performed between 0.4 to 1.60 μg/ml in the presence of metabolic activation. In the absence of metabolic activation, 10 to 90 μg/ml were tested. In the presence of metabolic activation, toxicity ranged from no cytotoxicity to high cytotoxicity (100% to 16% relative total growth). A concentration related increase was observed in the mutant frequency. However, it was weak and the highest induction of mutant frequency was observed at the highest concentration (1.6 μg/ml) tested with a mutant frequency of 32 x 10-6 greater than the control. This increase was much less than the required 90 induced mutants per 106 clonable cells above the control value for obtaining a positive response. In the absence of metabolic activation toxicity levels ranged from 94% relative total growth to 11% at the highest concentration. A clear concentration related increase in mutant frequency was observed. Treatments of 60, 70, and 90 μg/ml induced a mutant frequency that met the criteria for a positive response. Mutant colonies from the positive controls MMS (methyl methanesulfonate for testing without metabolic activation) and MCA (methylcholanthrene for testing with metabolic activation) treated cultures showed both small and large colonies. The test article doses (60, 70 and 90 μg/ml without metabolic activation) which exhibited a positive response, showed a preferential increase in small colonies indicating larger mutations.
Conclusion
Under the test conditions used 1 -naphthol is considered mutagenic in the absence of metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.